Kidney outcomes associated with SGLT2 inhibitors compared to other glucose-lowering drugs: a real-world study from China

被引：0
|
作者：
Xiao, Xiang [1 ]
机构：
[1] Sichuan Univ, West China Hosp, Chengdu, Peoples R China
来源：
NEPHROLOGY DIALYSIS TRANSPLANTATION | 2024年 / 39卷
关键词：
D O I：
10.1093/ndt/gfae069.1760
中图分类号：
R3 [基础医学]; R4 [临床医学];
学科分类号：
1001 ; 1002 ; 100602 ;
摘要：
1743
引用
收藏
页数：4
相关论文
共 50 条
  • [41] A Real-world Study Evaluating the Clinical Factors Associated with the Initial SGLT2 Inhibitor Prescription
    Chu, Michelle
    Lou, Mimi
    Wang, Mengxi
    Flores, Allison
    JOURNAL OF HEALTH CARE FOR THE POOR AND UNDERSERVED, 2024, 35 (03)
  • [42] THE PHOLLOW COHORT: REAL-WORLD THERAPEUTIC ADHERENCE TO BLOOD GLUCOSE-LOWERING DRUGS (EXCLUDING INSULINS) IN PORTUGAL
    Romao, M.
    Guerreiro, J.
    Rojais, C.
    Mendes, Z.
    Rodrigues, A.
    VALUE IN HEALTH, 2023, 26 (12) : S224 - S225
  • [43] Kidney outcomes of SGLT2 inhibitors among older patients with diabetic kidney disease in real-world clinical practice: the Japan Chronic Kidney Disease Database Ex
    Kitaoka, Kaori
    Yano, Yuichiro
    Nagasu, Hajime
    Kanegae, Hiroshi
    Chishima, Noriharu
    Akiyama, Hiroki
    Tamura, Kouichi
    Kashihara, Naoki
    BMJ OPEN DIABETES RESEARCH & CARE, 2024, 12 (03)
  • [44] SGLT2 inhibitors and vericiguat in real-world patients admitted for worsening heart failure
    Tarantini, R.
    Acone, L.
    Alonge, S.
    Catagnano, F.
    Foti, M.
    Oldani, M.
    Mortara, A.
    EUROPEAN HEART JOURNAL, 2023, 44
  • [45] SGLT2 inhibitors and amputation risk: Real-world data from a diabetes foot wound clinic
    Sung, Jasper
    Padmanabhan, Suja
    Gurung, Seema
    Inglis, Sally
    Vicaretti, Mauro
    Begg, Lindy
    Cheung, N. Wah
    Girgis, Christian M.
    JOURNAL OF CLINICAL AND TRANSLATIONAL ENDOCRINOLOGY, 2018, 13 : 46 - 47
  • [46] SGLT2 inhibitors in real-world patients with heart failure with preserved ejection fraction
    Tarantini, R.
    Vecchi, A. L.
    Matteo, F.
    De Ponti, R.
    Mortara, A.
    EUROPEAN HEART JOURNAL, 2022, 43 : 779 - 779
  • [47] Glucose-lowering agents and risk of ventricular arrhythmias and sudden cardiac death: A comprehensive review ranging from sulphonylureas to SGLT2 inhibitors
    Scheen, Andre J.
    DIABETES & METABOLISM, 2022, 48 (06)
  • [48] Real-World Safety and Efficacy of SGLT2 Inhibitors in Elderly Type 2 Diabetic Patients
    Trescoli, Carlos
    Fajardo, Carmen
    Aranzo, Jose
    Trescoli, Ana
    Garcia, Mar
    DIABETES, 2016, 65 : A595 - A595
  • [49] SGLT2 Inhibitors Are Associated With Reduced Cardiovascular Disease in Patients With Type 2 Diabetes: An Analysis of Real-World Data
    Wang, Wendy
    Chen, Lin Yee
    Walker, Rob F.
    Chow, Lisa S.
    Norby, Faye L.
    Alonso, Alvaro
    Pankow, James S.
    Lutsey, Pamela L.
    MAYO CLINIC PROCEEDINGS, 2023, 98 (07) : 985 - 996
  • [50] Introduction of SGLT2 Inhibitors and Variations in Other Disease-Modifying Drugs in Heart Failure Patients: A Single-Centre Real-World Experience
    Tabella, Erika
    Correale, Michele
    Alcidi, Gianmarco
    Pugliese, Rosanna
    Ioannoni, Sara
    Romano, Matteo
    Palmieri, Gianpaolo
    Di Biase, Matteo
    Brunetti, Natale Daniele
    Iacoviello, Massimo
    CLINICS AND PRACTICE, 2023, 13 (05) : 1015 - 1024
12345